These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1416887)

  • 1. Pharmacokinetics of [14C]FCE 22891, a penem antibiotic, following oral administration to healthy volunteers.
    Efthymiopoulos C; Strolin Benedetti M; Sassella D; Boobis A; Davies D
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1958-63. PubMed ID: 1416887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The disposition and urinary metabolism of 14C-labelled FCE 22891, a pro-drug of FCE 22101, in animals.
    Battaglia R; Benedetti MS; Frigerio E; Vicario G; Roncucci R
    J Antimicrob Chemother; 1990 Jan; 25(1):133-9. PubMed ID: 2318748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and metabolism of FCE 22101 following its administration as the oral pro-drug FCE 22891.
    Lovering AM; MacGowan AP; Lewis DA; Reeves DS
    J Antimicrob Chemother; 1992 Feb; 29(2):179-85. PubMed ID: 1506334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of FCE 22101 in man following different modes of administration.
    Lovering AM; White LO; Lewis DA; MacGowan AP; Routh KR; Pickin DM; Reeves DS
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():179-95. PubMed ID: 2732141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of FCE 22891, a new oral penem.
    Saathoff A; Lode H; Hampel B; Deppermann KM; Borner K; Koeppe P
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1001-6. PubMed ID: 2203300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics in healthy subjects of FCE 22101 and its acetoxymethyl ester, FCE 22891: effect of co-administration of imipenem/cilastatin on the renal metabolism of FCE 22101.
    Norrby SR; Burman LA; Sassella D; Corigli R; Cassinelli G; Franceschi G; Dornbusch K
    J Antimicrob Chemother; 1990 Mar; 25(3):371-83. PubMed ID: 2338416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tolerance of a new penem antibiotic, FCE 22101, in healthy volunteers after a single intravenous dose.
    Jannuzzo MG; Mandelli M; Benedetti MS; Moro E; Carnovali M; Vaiani R; Sassella D
    Eur J Clin Pharmacol; 1989; 36(6):633-5. PubMed ID: 2776823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary recovery and tolerability of FCE 22101 following single intravenous administration under restricted and high fluid intake.
    Sassella D; Cassinelli G; Corigli R; Dewland P; Hutt V; Lode H; Ballard RC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():197-203. PubMed ID: 2732142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics and tissue penetration of FCE 22101 following intravenous and oral administration.
    Webberley JM; Wise R; Andrews JM; Ashby JP; Wallbridge D
    J Antimicrob Chemother; 1988 Apr; 21(4):445-50. PubMed ID: 3378958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of an intravenously administered penem (Sch 34343) in humans.
    Lin CC; Lim J; Radwanski E; Kim HK; Marco A; Lapiguera A; DiGiore C; Symchowicz S
    Antimicrob Agents Chemother; 1987 Jan; 31(1):84-7. PubMed ID: 3566242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of 14C-labelled FCE 22101 in animals.
    Strolin Benedetti M; Goldaniga G; Montesanti L; Battaglia R; Vicario G
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():165-71. PubMed ID: 2732138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary metabolites of 14C-labelled FCE 22101 in animals.
    Strolin Benedetti M; Battaglia R; Vicario G; Roncucci R
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():173-7. PubMed ID: 2732140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and clinical tolerability of FCE 22101, a new penem antibiotic, in healthy volunteers after a single i.m. administration.
    Hitzenberger G; Strolin Benedetti M; Jannuzzo MG; Silvestri S; Moro E; Frigerio E; Sassella D
    J Chemother; 1989 Jul; 1(4 Suppl):513-4. PubMed ID: 16312509
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of the penem CP-65,207 and its separate stereoisomers in humans.
    Foulds G; Knirsch AK; Lazar JD; Tensfelt TG; Gerber N
    Antimicrob Agents Chemother; 1991 Apr; 35(4):665-71. PubMed ID: 2069372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of FCE 22101, a new penem antibiotic.
    Jannuzzo MG; Vaiani R; Strolin Benedetti M; Carnovali M; Cassinelli G; Corigli R
    J Chemother; 1989 Jul; 1(4 Suppl):511-2. PubMed ID: 16312508
    [No Abstract]   [Full Text] [Related]  

  • 17. Metabolic disposition of the acyclovir prodrug valaciclovir in the rat.
    Burnette TC; de Miranda P
    Drug Metab Dispos; 1994; 22(1):60-4. PubMed ID: 8149891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, metabolism, excretion and plasma protein binding of 14C-levofloxacin after a single oral administration in the Rhesus monkey.
    Hemeryck A; Mamidi RN; Bottacini M; Macpherson D; Kao M; Kelley MF
    Xenobiotica; 2006 Jul; 36(7):597-613. PubMed ID: 16864506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FCE 22101 and FCE 22891: in-vitro antibacterial activity at concentrations simulating human plasma levels following intravenous, intramuscular and oral administration.
    Della Bruna C; Jabes D; Rossi R; Younes G; Castellani P
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():119-28. PubMed ID: 2659570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.